Gail K. Naughton: Difference between revisions

(4 intermediate revisions by 2 users not shown)

Line 1:

'''Gail K. Naughton''' was president and COO of [[Advanced Tissue Sciences]], which produced a living skin product call [[Dermagraft]] used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of [[Shire]], a medical company based in Dublin, Ireland.

'''Gail K. Naughton''', Ph.D., MBA, B.S., was president and COO of [[Advanced Tissue Sciences]], which produced a living [[skin]] product call [[Dermagraft]] used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of [https://www.takeda.com/newsroom/newsreleases/2019/takeda-completes-acquisition-of-shire-becoming-a-global-values-based-rd-driven-biopharmaceutical-leader/ Shire], a medical company based in Dublin, Ireland.

Naughton founded [[Histogen]] in 2007, when she was dean of {{UNI|San Diego State University|SDSU}}'s College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on [[Histogen]].<ref>{{REFweb

Line 10:

|accessdate=2012-11-16

}}</ref>

* [[United States of America]]

* {{REFweb

|url=https://www.lji.org/team-member/gail-naughton-ph-d-mba/

|title=Gail K. Naughton, Ph.D., MBA

|last=

|first=

|init=

|publisher=La Jolla Institute for Imunology

|date=

|accessdate=2024-05-02

}}

Line 22:

Line 34:

[[Category:From CircLeaks]]

[[Category:From IntactWiki]]

[[Category:USA]]

[[de:{{FULLPAGENAME}}]]

@@ Line 1: / Line 1: @@
-'''Gail K. Naughton''' was president and COO of [[Advanced Tissue Sciences]], which produced a living skin product call [[Dermagraft]] used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of [[Shire]], a medical company based in Dublin, Ireland.
+'''Gail K. Naughton''', Ph.D., MBA, B.S., was president and COO of [[Advanced Tissue Sciences]], which produced a living [[skin]] product call [[Dermagraft]] used to help healing of diabetic foot ulcers. Dermagraft is now being made in San Diego by a subsidiary of [https://www.takeda.com/newsroom/newsreleases/2019/takeda-completes-acquisition-of-shire-becoming-a-global-values-based-rd-driven-biopharmaceutical-leader/ Shire], a medical company based in Dublin, Ireland.
 Naughton founded [[Histogen]] in 2007, when she was dean of {{UNI|San Diego State University|SDSU}}'s College of Business Administration. Naughton, who had been dean since 2002, left in 2010 to focus on [[Histogen]].<ref>{{REFweb
@@ Line 10: / Line 10: @@
   |accessdate=2012-11-16
 }}</ref>
+{{SEEALSO}}
+* [[United States of America]]
+{{LINKS}}
+* {{REFweb
+ |url=https://www.lji.org/team-member/gail-naughton-ph-d-mba/
+ |title=Gail K. Naughton, Ph.D., MBA
+ |last=
+ |first=
+ |init=
+ |publisher=La Jolla Institute for Imunology
+ |date=
+ |accessdate=2024-05-02
+}}
 {{REF}}
@@ Line 22: / Line 34: @@
 [[Category:From CircLeaks]]
 [[Category:From IntactWiki]]
+[[Category:USA]]
 [[de:{{FULLPAGENAME}}]]